Multiple sclerosis: a two-stage disease

doi:10.1038/ni0901-762

2001-09-01

560

PRE

Lawrence Steinman *

DOI：10.1038/ni0901-762

原文链接

原文求助

摘要

En 中文

The pathogenesis of multiple sclerosis consists of an inflammatory and neurodegnerative phase. Better understanding of these stages has aided the development of specific therapeutic targets.

Keyword:

PEPTIDE

SCREEN

CELL

AI总结

对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Nature Immunology

IF:

27.6

论文数:

6.4K

被引数:

5.6W

机构

暂无机构信息

引用论文

Spinal cord atrophy and disability in multiple sclerosis - A new reproducible and sensitive MRI method with potential to monitor disease progression 多发性硬化症中的脊髓萎缩和残疾-一种新的可重复且敏感的MRI方法，具有监测疾病进展的潜力

BRAIN

IF11.7

1996-01-01

580

OAAI

Losseff, NA; Webb, SL; ORiordan, JI; Page, R; Wang, L; Barker, GJ; Tofts, PS; McDonald, WI; Miller, DH; Thompson, AJ

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

NATURE GENETICS

IF31.8

1996-08-01

605

PREAI

Sawcer, S; Jones, HB; Feakes, R; Gray, J; Smaldon, N; Chataway, J; Robertson, N; Clayton, D; Goodfellow, PN; Compston, A

Glutamate excitotoxicity in a model of multiple sclerosis

NATURE MEDICINE

IF50

2000-01-01

791

PREAI

Pitt, D; Werner, P; Raine, CS

Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis

BRAIN PATHOLOGY

IF6.2

2008-01-28

700

OAAI

Lucchinetti, CF; Bruck, W; Rodriguez, M; Lassmann, H

Axonal transection in the lesions of multiple sclerosis

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

1998-01-29

3.6K

OAAI

Trapp, BD; Peterson, J; Ransohoff, RM; Rudick, R; Mörk, S; Bö, L

The immunobiology of multiple sclerosis: An autoimmune disease of the central nervous system

NEUROBIOLOGY OF DISEASE

IF5.6

1999-06-01

PREAI

Conlon, P; Oksenberg, JR; Zhang, JQ; Steinman, L

A full genome search in multiple sclerosis

NATURE GENETICS

IF31.8

1996-08-01

603

PREAI

Ebers, GC; Kukay, K; Bulman, DE; Sadovnick, AD; Rice, G; Anderson, C; Armstrong, H; Cousin, K; Bell, RB; Hader, W; Paty, DW; Hashimoto, S; Oger, J; Duquette, P; Warren, S; Gray, T; OConnor, P; Nath, A; Auty, A; Metz, L; Francis, G; Paulseth, JE; Murray, TJ; PrysePhillips, W; Nelson, R; Freedman, M; Brunet, D; Bouchard, JP; Hinds, D; Risch, N

Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients - Identity of key contact residues in the B-cell and T-cell epitopes

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

1997-09-01

195

OAAI

Wucherpfennig, KW; Catz, I; Hausmann, S; Strominger, JL; Steinman, L; Warren, KG

A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex

NATURE GENETICS

IF31.8

1996-08-01

620

PREAI

Haines, JL; TerMinassian, M; Bazyk, A; Gusella, JF; Kim, DJ; Terwedow, H; PericakVance, MA; Rimmler, JB; Haynes, CS; Roses, AD; Lee, A; Shaner, B; Menold, M; Seboun, E; Fitoussi, RP; Gartioux, C; Reyes, C; Ribierre, F; Gyapay, G; Weissenbach, J; Hauser, SL; Goodkin, DE; Lincoln, R; Usuku, K; GarciaMerino, A; Gatto, N; Young, S; Oksenberg, JR

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

NATURE MEDICINE

IF50

2000-10-01

498

PREAI

Kappos, L; Comi, G; Panitch, H; Oger, J; Antel, J; Conlon, P; Steinman, L

没有更多内容